Advances in protein design and enzyme engineering now allow for the rapid modification of bioactive
Ivan Kairatov stands at the forefront of the biopharmaceutical evolution, where traditional
The treatment landscape for pancreatic ductal adenocarcinoma has long been characterized by a disheartening series of clinical failures and marginal survival improvements that left patients with few viable options. However, the emergence of daraxonrasib, a specialized oral RAS(ON) multi-selective
The quest to recreate the intricate complexity of human tissue within a laboratory setting has long been hindered by the limitations of static synthetic materials that fail to communicate with living cells. As bioengineering transitions from simple scaffolds to dynamic, interactive systems,
The intersection of computational intelligence and molecular biology has revealed a shocking source
The race to treat Alzheimer’s has entered a new era with the approval of monoclonal antibody

Advanced Therapy Medicinal Products cannot be scaled the same way biologics were. The core constraint is not steel and glass. It is biology, variability, and a regulatory environment that requires…

The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at

In 2026, boards and customers are asking a direct question: can promising science be turned into

The pharmaceutical sector is entering a decisive phase as obesity therapeutics gain more ground as

The End of the Old Biopharma Playbook The biopharmaceutical industry is confronting a structural
The silent hum of data processing centers has become as much a fixture of the modern medical ward as the rhythmic beep of a heart monitor, yet this digital transformation carries significant hidden risks. Unlike administrative AI used for scheduling, clinical decision support tools enter the
Advances in protein design and enzyme engineering now allow for the rapid modification of bioactive
By identifying relevant microscopic patterns across large image patches, new AI models can process